Latest Industry Insights

HPLC system manufacturers have been striving to improve usability, accessibility and help users improve their experimental outcomes. And what better way to do that than to involve the users themselves in that development process.

Dr. Andreas Boehmler explores how the arrival of new flow cytometry platforms finally puts powerful automation within reach for many labs, allowing operators to enumerate stem cells more quickly and accurately for transplant.

To learn more about the waters_connect^TM System Monitoring Software and the benefits it offers, Technology Networks spoke to Dave Leitham.

We spoke with Bio-Rad’s Justin Barker to discover some of the challenges associated with gene expression analysis in oncology and learn about technology developments in this field.

Technology Networks had the pleasure of speaking with Dr. Maddison Masaeli, co-founder and chief executive officer at Deepcell to learn about the REM-I platform, a single-cell analysis tool that utilizes AI-powered imaging to magnify insights into a cell’s phenotype and function.

We spoke to Prof. Oscar Ces, head of the Department of Chemistry at Imperial College London (ICL), to find out about the evolution of ICL’s White City Campus, the Agilent Measurement Suite and what it means for scientists across the board.

Misha Bashkurov explores how image analysis software with deep learning capabilities can directly address the convoluted and confusing process of traditional image analysis, which often leads to user frustration, bias results, time lost and increased costs.

Cutting-edge mass spectrometry proteomics technologies are accelerating the discovery and validation of novel targets in cancer, opening up new avenues for next-generation cancer therapeutics.

Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.

New applications for RNA therapeutics are continuously emerging. In this burgeoning space, nucleic acid quantification can help this dynamic therapeutic modality reach its full potential.